Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Ultrasensitive quantitative measurement of huntingtin phosphorylation at residue S13.

Cariulo C, Verani M, Martufi P, Ingenito R, Finotto M, Deguire SM, Lavery DJ, Toledo-Sherman L, Lee R, Doherty EM, Vogt TF, Dominguez C, Lashuel HA, Petricca L, Caricasole A.

Biochem Biophys Res Commun. 2020 Jan 15;521(3):549-554. doi: 10.1016/j.bbrc.2019.09.097. Epub 2019 Oct 31.

PMID:
31677786
2.

Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study.

Manfredi A, Cassone G, Furini F, Gremese E, Venerito V, Atzeni F, Arrigoni E, Della Casa G, Cerri S, Govoni M, Petricca L, Iannone F, Salvarani C, Sebastiani M.

Intern Med J. 2019 Oct 29. doi: 10.1111/imj.14670. [Epub ahead of print]

PMID:
31661185
3.

Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity.

Benucci M, Grossi V, Manfredi M, Damiani A, Infantino M, Moscato P, Cinquanta L, Gremese E, Tolusso B, Petricca L, Fedele AL, Alivernini S, Atzeni F, Minisola G, Verna R.

Ann Lab Med. 2020 Mar;40(2):101-113. doi: 10.3343/alm.2020.40.2.101. Review.

4.

Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay.

Cariulo C, Martufi P, Verani M, Azzollini L, Bruni G, Weiss A, Deguire SM, Lashuel HA, Scaricamazza E, Sancesario GM, Schirinzi T, Mercuri NB, Sancesario G, Caricasole A, Petricca L.

Front Neurosci. 2019 Aug 22;13:889. doi: 10.3389/fnins.2019.00889. eCollection 2019.

5.

Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis.

Alivernini S, Tolusso B, Gigante MR, Petricca L, Bui L, Fedele AL, Di Mario C, Benvenuto R, Federico F, Ferraccioli G, Gremese E.

Sci Rep. 2019 Jul 18;9(1):10420. doi: 10.1038/s41598-019-46927-w.

6.

Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis.

Alivernini S, Bruno D, Tolusso B, Bui L, Petricca L, Gigante MR, Birra D, Fedele AL, Peluso G, Federico F, Ferraccioli G, Gremese E.

Arthritis Res Ther. 2019 May 9;21(1):116. doi: 10.1186/s13075-019-1898-7.

7.

Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington's disease.

Vezzoli E, Caron I, Talpo F, Besusso D, Conforti P, Battaglia E, Sogne E, Falqui A, Petricca L, Verani M, Martufi P, Caricasole A, Bresciani A, Cecchetti O, Rivetti di Val Cervo P, Sancini G, Riess O, Nguyen H, Seipold L, Saftig P, Biella G, Cattaneo E, Zuccato C.

J Clin Invest. 2019 May 6;129(6):2390-2403. doi: 10.1172/JCI120616. eCollection 2019 May 6.

8.

Correction to: Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve.

Di Mario C, Petricca L, Gigante MR, Barini A, Barini A, Varriano V, Paglionico A, Cattani P, Ferraccioli G, Tolusso B, Gremese E.

Endocrine. 2019 Feb;63(2):405. doi: 10.1007/s12020-018-1811-1.

PMID:
30506360
9.

Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve.

Di Mario C, Petricca L, Gigante MR, Barini A, Barini A, Varriano V, Paglionico A, Cattani P, Ferraccioli G, Tolusso B, Gremese E.

Endocrine. 2019 Feb;63(2):369-375. doi: 10.1007/s12020-018-1783-1. Epub 2018 Oct 15. Erratum in: Endocrine. 2018 Dec 1;:.

PMID:
30324323
10.

Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA.

Frasca L, Palazzo R, Chimenti MS, Alivernini S, Tolusso B, Bui L, Botti E, Giunta A, Bianchi L, Petricca L, Auteri SE, Spadaro F, Fonti GL, Falchi M, Evangelista A, Marinari B, Pietraforte I, Spinelli FR, Colasanti T, Alessandri C, Conti F, Gremese E, Costanzo A, Valesini G, Perricone R, Lande R.

Front Immunol. 2018 Sep 12;9:1936. doi: 10.3389/fimmu.2018.01936. eCollection 2018.

11.

Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis.

Tolusso B, Gigante MR, Alivernini S, Petricca L, Fedele AL, Di Mario C, Aquilanti B, Magurano MR, Ferraccioli G, Gremese E.

Front Med (Lausanne). 2018 Aug 3;5:207. doi: 10.3389/fmed.2018.00207. eCollection 2018.

12.

Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features.

Alivernini S, Tolusso B, Petricca L, Bui L, Di Mario C, Gigante MR, Di Sante G, Benvenuto R, Fedele AL, Federico F, Ferraccioli G, Gremese E.

Front Med (Lausanne). 2018 Jul 3;5:186. doi: 10.3389/fmed.2018.00186. eCollection 2018.

13.

Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis.

Alivernini S, Pugliese D, Tolusso B, Bui L, Petricca L, Guidi L, Mirone L, Rapaccini GL, Federico F, Ferraccioli G, Armuzzi A, Gremese E.

RMD Open. 2018 Apr 9;4(1):e000667. doi: 10.1136/rmdopen-2018-000667. eCollection 2018.

14.

Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy.

Fedele AL, Petricca L, Tolusso B, Alivernini S, Canestri S, Di Mario C, Bosello SL, Ferraccioli G, Gremese E.

Scand J Rheumatol. 2018 Sep;47(5):351-359. doi: 10.1080/03009742.2017.1416668. Epub 2018 Mar 15.

PMID:
29542372
15.

Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformation.

Cariulo C, Azzollini L, Verani M, Martufi P, Boggio R, Chiki A, Deguire SM, Cherubini M, Gines S, Marsh JL, Conforti P, Cattaneo E, Santimone I, Squitieri F, Lashuel HA, Petricca L, Caricasole A.

Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):E10809-E10818. doi: 10.1073/pnas.1705372114. Epub 2017 Nov 21.

16.

Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models.

Daldin M, Fodale V, Cariulo C, Azzollini L, Verani M, Martufi P, Spiezia MC, Deguire SM, Cherubini M, Macdonald D, Weiss A, Bresciani A, Vonsattel JG, Petricca L, Marsh JL, Gines S, Santimone I, Marano M, Lashuel HA, Squitieri F, Caricasole A.

Sci Rep. 2017 Jul 11;7(1):5070. doi: 10.1038/s41598-017-05336-7.

17.

MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis.

Kurowska-Stolarska M, Alivernini S, Melchor EG, Elmesmari A, Tolusso B, Tange C, Petricca L, Gilchrist DS, Di Sante G, Keijzer C, Stewart L, Di Mario C, Morrison V, Brewer JM, Porter D, Milling S, Baxter RD, McCarey D, Gremese E, Lemke G, Ferraccioli G, McSharry C, McInnes IB.

Nat Commun. 2017 Jun 22;8:15877. doi: 10.1038/ncomms15877.

18.

Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?

Alivernini S, Tolusso B, Petricca L, Bui L, Di Sante G, Peluso G, Benvenuto R, Fedele AL, Federico F, Ferraccioli G, Gremese E.

Ann Rheum Dis. 2017 Jul;76(7):1228-1236. doi: 10.1136/annrheumdis-2016-210424. Epub 2017 Jan 24.

19.

MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis.

Alivernini S, Kurowska-Stolarska M, Tolusso B, Benvenuto R, Elmesmari A, Canestri S, Petricca L, Mangoni A, Fedele AL, Di Mario C, Gigante MR, Gremese E, McInnes IB, Ferraccioli G.

Nat Commun. 2016 Sep 27;7:12970. doi: 10.1038/ncomms12970.

20.

Conformational modulation mediated by polyglutamine expansion in CAG repeat expansion disease-associated proteins.

Verani M, Bustamante M, Martufi P, Daldin M, Cariulo C, Azzollini L, Fodale V, Puglisi F, Weiss A, Macdonald D, Petricca L, Caricasole A.

Biochem Biophys Res Commun. 2016 Sep 16;478(2):949-55. doi: 10.1016/j.bbrc.2016.08.057. Epub 2016 Aug 9.

PMID:
27520369
21.

Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone.

Carbonella A, Berardi G, Petricca L, Biscetti F, Alivernini S, Bosello SL, Fedele AL, Ferraccioli G, Gremese E.

J Am Geriatr Soc. 2016 Mar;64(3):672-374. doi: 10.1111/jgs.14004. No abstract available.

PMID:
27000356
22.

Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery.

Ceccarelli I, Fiengo P, Remelli R, Miragliotta V, Rossini L, Biotti I, Cappelli A, Petricca L, La Rosa S, Caricasole A, Pollio G, Scali C.

Neurobiol Dis. 2016 Feb;86:41-51. doi: 10.1016/j.nbd.2015.11.019. Epub 2015 Nov 25.

PMID:
26626080
23.

Detection of huntingtin exon 1 phosphorylation by Phos-Tag SDS-PAGE: Predominant phosphorylation on threonine 3 and regulation by IKKβ.

Bustamante MB, Ansaloni A, Pedersen JF, Azzollini L, Cariulo C, Wang ZM, Petricca L, Verani M, Puglisi F, Park H, Lashuel H, Caricasole A.

Biochem Biophys Res Commun. 2015 Aug 7;463(4):1317-22. doi: 10.1016/j.bbrc.2015.06.116. Epub 2015 Jun 21.

PMID:
26106822
24.

Polyglutamine- and temperature-dependent conformational rigidity in mutant huntingtin revealed by immunoassays and circular dichroism spectroscopy.

Fodale V, Kegulian NC, Verani M, Cariulo C, Azzollini L, Petricca L, Daldin M, Boggio R, Padova A, Kuhn R, Pacifici R, Macdonald D, Schoenfeld RC, Park H, Isas JM, Langen R, Weiss A, Caricasole A.

PLoS One. 2014 Dec 2;9(12):e112262. doi: 10.1371/journal.pone.0112262. eCollection 2014. Erratum in: PLoS One. 2015;10(6):e0129986.

25.

Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells.

Massai L, Petricca L, Magnoni L, Rovetini L, Haider S, Andre R, Tabrizi SJ, Süssmuth SD, Landwehrmeyer BG, Caricasole A, Pollio G, Bernocco S.

BMC Biochem. 2013 Nov 25;14:34. doi: 10.1186/1471-2091-14-34.

26.

Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus.

Frezza D, Tolusso B, Giambra V, Gremese E, Marchini M, Nowik M, Serone E, D'Addabbo P, Mattioli C, Canestri S, Petricca L, D'Antona G, Birshtein BK, Scorza R, Ferraccioli G.

Ann Rheum Dis. 2012 Aug;71(8):1309-15. doi: 10.1136/ard.2010.147025. Epub 2012 Jan 31.

PMID:
22294636
27.

B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status.

Michelutti A, Gremese E, Morassi F, Petricca L, Arena V, Tolusso B, Alivernini S, Peluso G, Bosello SL, Ferraccioli G.

Mol Med. 2011 Sep-Oct;17(9-10):901-9. doi: 10.2119/molmed.2011.00034. Epub 2011 May 13.

28.

Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes.

Valenza M, Leoni V, Karasinska JM, Petricca L, Fan J, Carroll J, Pouladi MA, Fossale E, Nguyen HP, Riess O, MacDonald M, Wellington C, DiDonato S, Hayden M, Cattaneo E.

J Neurosci. 2010 Aug 11;30(32):10844-50. doi: 10.1523/JNEUROSCI.0917-10.2010.

29.

Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios.

Pietrapertosa D, Tolusso B, Gremese E, Papalia MC, Bosello SL, Peluso G, Petricca L, Michelutti A, Faustini F, Fedele AL, Ferraccioli G.

Clin Chem Lab Med. 2010 Jun;48(6):829-34. doi: 10.1515/CCLM.2010.152.

PMID:
20298138

Supplemental Content

Loading ...
Support Center